The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC).
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; ARIAD; Boehringer Ingelheim
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech/Roche (Inst)
 
Rolf A. Stahel
Honoraria - Astellas Pharma; AstraZeneca; Lilly; MSD; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Lukas Bubendorf
Stock and Other Ownership Interests - Roche
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Philip Bonomi
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
 
Augusto E. Villegas
Honoraria - Alexion Pharmaceuticals; Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Dariusz Kowalski
No Relationships to Disclose
 
Christina S. Baik
Consulting or Advisory Role - Novartis
Research Funding - Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Millennium (Inst); Novartis (Inst)
 
Dolores Isla
No Relationships to Disclose
 
Javier De Castro
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Roche
 
Pilar Garrido Lopez
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Achim Rittmeyer
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche/Genentech
 
Marcello Tiseo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; NS Pharma; Otsuka; Pierre Fabre
 
Sven Franz Stanzel
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Sanne de Haas
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Lisa Lam
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Michael Lu
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Solange Peters
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Roche